In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Innovation

Set Alert for Innovation

Data Governance Key In Maximizing Value Of Electronic Health Information

As of 5 April, 2021, health care providers, health IT developers and health information exchanges in the US face penalties for blocking the free exchange of electronic health information, including patient requests for health records. But strong data governance policies are needed to make health information serve patient needs, according to a Prix Galien panel of experts.

Digital Health Healthcare Systems

Alchemab Targets ‘List Of The Worst-Served Diseases’

In an exclusive interview, Alchemab CEO Alex Leech talks to In Vivo about the company’s method of identifying naturally occurring antibodies to target high unmet needs in oncology, neurodegeneration and infectious diseases.

Financing Innovation

Data Gathering Devices Offer Big Potential In Neurological Drug Trials

As wearable technologies and other devices become capable of recording large amounts of data for use in clinical trials, industry experts are asking why pharma has been slow to maximize the opportunity in product development.

Clinical Trials Digital Health

Using Oncology Patient Monitoring Data To Improve Outcomes

Through a grant from the National Cancer Institute (NCI), Charles River Analytics is building a platform to collect and analyze biometric sensor data and connected devices used by cancer patients across the US. The goal of the project is to support large-scale population health research and to improve cancer outcomes.

Artificial Intelligence Clinical Trials

COVID-19 Vaccination Programs And Implications Of The Human Microbiome

It is vital to understand the role of the microbiome in immunity and vaccine response, and how the microbiome may impact the effectiveness of COVID-19 vaccine programs in the real world.

Vaccines Clinical Trials

COVID-19 Made Its Mark On the R&D Pipeline And Novel Drug Launches In 2020

A new analysis reveals the impact of the coronavirus pandemic on pharma R&D in 2020 in two quarters: the total size of the pipeline and in the number of novel products launched in their first markets.

Commercial Companies

The Growing GLP-1 Therapy Market

Novo Nordisk was not the first biopharmaceutical company to launch a GLP-1 therapy into the market for type 2 diabetes. In fact, Amylin Pharmaceutials’ and Eli Lilly’s Byetta (exenatide) beat Novo’s Victoza (liraglutide) to market by a full five years.  

Innovation BioPharmaceutical

Pandemic Puts A Spotlight On Counterfeit Drugs

As the ongoing COVID-19 pandemic forces health care to go digital, opportunities for fraud have proliferated. In Vivo explores the risks, the steps regulators are taking and how companies are looking to provide innovative solutions to help secure manufacturing supply chains.

C-Suite Speaks Drug Safety

Re-Configuring Pharma Operations Amid Pandemic Strains

Senior McKinsey executive shares insights on the potential contours of pharma’s 'reimagined' operations against the backdrop of COVID-19 and striking a balance between supply chain security and the cost component. A dramatic near-term shift to a “completely onshore model” in markets like the US would not realistically be possible, he indicated.

Innovation Manufacturing

BTG SP Makes A Virtue Of Manufacturing And Supply Discipline Despite COVID

Manufacturing and supply chain resilience ensured that BTG Specialty Pharma met its sales target in the COVID-affected 2020. Its president, Anthony Higham, explained how this was possible while the company busily  ̶  and quietly – sought new ownership, and all under the shadow of Brexit.

Business Strategies Innovation

Medtech Start-Ups Seeking Corporate Deals Must Know Type Of Success They Want

Missteps and misconceptions are rife among medtech start-ups when it comes to their next strategic move en route to market or to exit.

Innovation Medical Device

Could Automation Rescue CAR-T Manufacturing?

Manufacturing constraints have prevented even the most pioneering cell therapy companies from meeting patient demand for their life-saving treatments. They are still in the works, but could fully automated, closed manufacturing platforms be potential game changers?

Business Strategies Commercial
See All
UsernamePublicRestriction

Register